Drug Database
Back to search

Poland· PL-100204018

Beriplex P/N 250

A coagulation factor ix, ii, vii and x in combination product containing prothrombinum multiplex humanum, registered in Poland by CSL Behring GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC B02BD01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedBeriplex P/N 250ATCB02BD01REGISTER NO.PL-100204018PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about prothrombinum multiplex humanumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Coagulation factor ix, ii, vii and x in combination is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BD01 (coagulation factor ix, ii, vii and x in combination), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search coagulation factor ix, ii, vii and x in combination products by name

Coagulation factor ix, ii, vii and x in combination · ATC B02BD01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Prothrombinum multiplex humanum
Manufacturer
CSL Behring GmbH
Country
Poland (PL)
ATC code
B02BD01
ATC class
Coagulation factor IX, II, VII and X in combination
Defined daily dose
1.6 TSD, E
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990679171

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for coagulation factor ix, ii, vii and x in combination.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check coagulation factor ix, ii, vii and x in combination against other medicinesHow interaction checks work

Coagulation factor ix, ii, vii and x in combination · interactions on record

3 records

  • 2 severe
  • 1 moderate

Most severe, free to view

  • CarfilzomibL01XG02severe
  • CarfilzomibL01XX45severe
  • PegvaliaseA16AB19moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Coagulation factor ix, ii, vii and x in combination in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All coagulation factor ix, ii, vii and x in combination products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9c06ce21-f40c-4ef1-b3c4-1e1f2efa4724
GET /v1/drugs/9c06ce21-f40c-4ef1-b3c4-1e1f2efa4724?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań",
  "source": "urpl",
  "strength": "250 j.m.",
  "packaging": "05909990679171 ¦ Rp ¦ 48089\n1 fiol.  proszku ¦ 1 system  transferowy 20/20 z filtrem ¦ 1 fiol. 10 ml rozp.",
  "substance": "Factor II coagulationis humanus 200-480 j.m. (składnik zespołu ludzkiej protrombiny) + Factor VII coagulationis humanus 100-250 j.m. (składnik zespołu ludzkiej protrombiny) + Factor IX coagulationis humanus 200-310 j.m. (składnik zespołu ludzkiej protrombiny) + Factor X coagulationis humanus 220-600 j.m. (składnik zespołu ludzkiej protrombiny) + Białko C 150-450 j.m. (składnik zespołu ludzkiej protrombiny) + Białko S 130-260 j.m. (składnik zespołu ludzkiej protrombiny)",
  "common_name": "Prothrombinum multiplex humanum",
  "pl_product_id": "100204018",
  "pozwolenie_nr": "15102",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about coagulation factor ix, ii, vii and x in combination.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console